Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
2005 1
2007 2
2009 2
2011 2
2013 1
2018 2
2022 1
2023 6
2024 4
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Real-world experience with targeted therapy in patients with histiocytic neoplasms in the Netherlands and in Belgium.
Kemps PG, Woei-A-Jin FJSH, Schöffski P, Tousseyn T, Vanden Bempt I, Meyer-Wentrup FAG, Dors N, van Eijkelenburg NKA, Scheijde-Vermeulen MA, Jazet IM, Limper M, Jak M, Verdijk RM, Donker ML, de Jonge NA, van Noesel CJM, Hebeda KM, van Dorp S, Tonino SH, van Laar JAM, van den Bos C, van Halteren AGS; HOVON Histiocytic and Lymphocytic Diseases Working Group. Kemps PG, et al. Among authors: jak m. Blood Neoplasia. 2024 Jun 10;1(3):100023. doi: 10.1016/j.bneo.2024.100023. eCollection 2024 Sep. Blood Neoplasia. 2024. PMID: 40453055 Free PMC article.
Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group.
Spanjaart AM, Ljungman P, Tridello G, Schwartz J, Martinez-Cibrián N, Barba P, Kwon M, Lopez-Corral L, Martinez-Lopez J, Ferra C, Di Blasi R, Ghesquieres H, Mutsaers P, Calkoen F, Jak M, van Doesum J, Vermaat JSP, van der Poel M, Maertens J, Gambella M, Metafuni E, Ciceri F, Saccardi R, Nicholson E, Tholouli E, Matthew C, Potter V, Bloor A, Besley C, Roddie C, Wilson K, Nagler A, Campos A, Petersen SL, Folber F, Bader P, Finke J, Kroger N, Knelange N, de La Camara R, Kersten MJ, Mielke S. Spanjaart AM, et al. Among authors: jak m. Leukemia. 2024 Sep;38(9):1985-1991. doi: 10.1038/s41375-024-02336-1. Epub 2024 Jul 23. Leukemia. 2024. PMID: 39043963 Free PMC article.
Population-based validation of the CAR-HEMATOTOX for hematotoxicity, infections, and survival after CART in R/R LBCL.
de Boer JW, Keijzer K, van Dorp S, Mutsaers PGNJ, Niezink AGH, van Doesum JA, Serroukh YIM, Muntendam LW, Pulles AE, Kret EJ, Sijs-Szabo A, Oomen J, Demandt AMP, Stevens WBC, Kuipers MT, Pennings ERA, Spanjaart AM, Kersten MJ, Jak M, van Dijk LV, van der Poel MWM, Vermaat JSP, van Meerten T. de Boer JW, et al. Among authors: jak m. Blood Adv. 2025 Nov 11;9(21):5641-5650. doi: 10.1182/bloodadvances.2025016689. Blood Adv. 2025. PMID: 40668622 Free article.
Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy Toxicities.
Spanjaart AM, Pennings ERA, Kos M, Mutsaers PGNJ, Lugtenburg PJ, van Meerten T, van Doesum JA, Minnema MC, Jak M, van Dorp S, Vermaat JSP, van der Poel MWM, van Oijen MGH, Kuipers MT, Nijhof IS, Kersten MJ. Spanjaart AM, et al. Among authors: jak m. JCO Oncol Pract. 2023 Mar;19(3):e407-e416. doi: 10.1200/OP.22.00501. Epub 2022 Dec 12. JCO Oncol Pract. 2023. PMID: 36508702 Free PMC article.
Inflammatory reactions mimic residual or recurrent lymphoma on [18F]FDG-PET/CT after CD19-directed CAR T-cell therapy.
de Boer JW, Pennings ERA, Kleinjan A, van Doesum JA, Spanjaart AM, Mutsaers PGNJ, Jak M, van der Poel MWM, Kuipers MT, Adam JA, Diepstra A, Koens L, van Dorp S, Vermaat JSP, Niezink AGH, Kersten MJ, van Meerten T. de Boer JW, et al. Among authors: jak m. Blood Adv. 2023 Nov 14;7(21):6710-6716. doi: 10.1182/bloodadvances.2023010665. Blood Adv. 2023. PMID: 37639324 Free PMC article. No abstract available.
Population-Based External Validation of the EASIX Scores to Predict CAR T-Cell-Related Toxicities.
de Boer JW, Keijzer K, Pennings ERA, van Doesum JA, Spanjaart AM, Jak M, Mutsaers PGNJ, van Dorp S, Vermaat JSP, van der Poel MWM, van Dijk LV, Kersten MJ, Niezink AGH, van Meerten T; Dutch CAR-T Tumorboard Consortium. de Boer JW, et al. Among authors: jak m. Cancers (Basel). 2023 Nov 16;15(22):5443. doi: 10.3390/cancers15225443. Cancers (Basel). 2023. PMID: 38001703 Free PMC article.
22 results